Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | PPARD | Q03181 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.33 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | FNTA | P49354 | 1/20 | 0.30 |
| ▸ | FNTB | P49356 | 1/20 | 0.30 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28638981 | 0.86 | ZDHHC20 (0.35) | TSHRALDH1A1TDP1MAPK1ZDHHC20 | |
| SCHEMBL9815384 | 0.81 | TSHR (0.41) | TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL28150271 | 0.80 | CHRM5 (0.37) | TSHRMAPK1 | |
| SCHEMBL28432765 | 0.78 | TSHR (0.35) | TSHRALDH1A1TDP1MAPK1ZDHHC20 | |
| SCHEMBL8520668 | 0.77 | PPARD (0.38) | TSHRPPARDALDH1A1TDP1CA12 | |
| SCHEMBL27872966 | 0.77 | TSHR (0.36) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL16402987 | 0.76 | TDP1 (0.35) | TSHRALDH1A1TDP1MAPK1FNTA | |
| SCHEMBL28963629 | 0.75 | PPARD (0.33) | TSHRPPARDALDH1A1TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL27555998 | 0.75 | LMNA (0.43) | TSHRPPARDALDH1A1TDP1CA12 | |
| SCHEMBL27813651 | 0.75 | TSHR (0.37) | TSHRALDH1A1TDP1MAPK1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1508042-A4 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | BIO RAD LABORATORIES (US) | 2008-04-02 | — | — | EP | claimed |
| EP-1508042-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | Ciphergen Biosystems, Inc. (US) | 2005-02-23 | — | — | EP | claimed |
| US-20030218130-A1 | Biochips with surfaces coated with polysaccharide-based hydrogels | CIPHERGEN BIOSYSTEMS, INC. | 2003-11-27 | — | — | US | claimed |
| WO-2003093785-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | CIPHERGEN BIOSYSTEMS, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| CN-119731560-A | Contact lens having hydrogel coating thereon | 爱尔康公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-2909606-B1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES | UNIV MARYLAND (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-115772245-A | High-robustness phosphate water reducing agent special for self-compacting concrete and preparation method thereof | 深中通道管理中心 | 2023-03-10 | — | — | CN | disclosed |
| CN-112745464-A | Phosphate-containing high-adaptability early-strength polycarboxylate superplasticizer and preparation method and application thereof | 广州市建筑科学研究院有限公司 | 2021-05-04 | — | — | CN | disclosed |
| EP-3540429-B1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMIA | UNIV MARYLAND (US) | 2020-11-11 | — | — | EP | disclosed |
| US-10620187-B2 | Device and methods of using device for detection of hyperammonemia | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2020-04-14 | — | — | US | disclosed |
| US-10591495-B2 | Device and methods of using device for detection of hyperammonemia | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2020-03-17 | — | — | US | disclosed |
| EP-3540429-A1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMIA | University of Maryland, College Park (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2015031911-A1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMIA | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2015-03-05 | — | — | WO | disclosed |
| WO-2014062985-A1 | DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES | UNIVERSITY OF MARYLAND, OFFICE OF TECHNOLOGY COMMERCIALIZATION (US) | 2014-04-24 | — | — | WO | disclosed |
| US-8092993-B2 | Hydrogel thin film for use as a biosensor | NELLCOR PURITAN BENNETT LLC (US) | 2012-01-10 | — | — | US | disclosed |
| US-20090170124-A1 | HYDROGEL THIN FILM FOR USE AS A BIOSENSOR | NELLCOR PURITAN BENNETT LLC (US) | 2009-07-02 | — | — | US | disclosed |
| EP-1508042-A4 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | BIO RAD LABORATORIES (US) | 2008-04-02 | — | — | EP | disclosed |
| EP-1508042-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | Ciphergen Biosystems, Inc. (US) | 2005-02-23 | — | — | EP | disclosed |
| US-20030218130-A1 | Biochips with surfaces coated with polysaccharide-based hydrogels | CIPHERGEN BIOSYSTEMS, INC. | 2003-11-27 | — | — | US | disclosed |
| WO-2003093785-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | CIPHERGEN BIOSYSTEMS, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10591495-B2 | Device and methods of using device for detection of hyperammonemia | ASS1, ALPL, SLCO2B1 | TSHR 2398/4885PPARD 3367/4885ALDH1A1 1469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.